Virax Historical Balance Sheet
| VRAX Stock | USD 1.90 0.04 2.06% |
Trend analysis of Virax Biolabs Group balance sheet accounts such as Total Assets of 3.4 M, Short Long Term Debt Total of 210.1 K, Other Current Liabilities of 16.6 K or Total Current Liabilities of 160.4 K provides information on Virax Biolabs' total assets, liabilities, and equity, which is the actual value of Virax Biolabs Group to its prevalent stockholders. By breaking down trends over time using Virax Biolabs balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Virax Biolabs Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Virax Biolabs Group is a good buy for the upcoming year.
Virax Biolabs Inventory |
|
Virax |
About Virax Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Virax Biolabs Group at a specified time, usually calculated after every quarter, six months, or one year. Virax Biolabs Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Virax Biolabs and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Virax currently owns. An asset can also be divided into two categories, current and non-current.
Virax Biolabs Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Virax Biolabs assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Virax Biolabs Group books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Virax Biolabs balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Virax Biolabs Group are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Accounts Payable
An accounting item on the balance sheet that represents Virax Biolabs obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Virax Biolabs Group are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Virax Biolabs Group balance sheet. This account contains Virax Biolabs investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Virax Biolabs Group fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Most accounts from Virax Biolabs' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Virax Biolabs Group current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Virax Biolabs Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At this time, Virax Biolabs' Other Current Assets are fairly stable compared to the past year.
| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 3.8K | 146.3K | 224.3K | 210.1K | Total Assets | 48.7K | 9.8M | 5.5M | 3.4M |
Virax Biolabs balance sheet Correlations
Click cells to compare fundamentals
Virax Biolabs Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Virax Stock Analysis
When running Virax Biolabs' price analysis, check to measure Virax Biolabs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virax Biolabs is operating at the current time. Most of Virax Biolabs' value examination focuses on studying past and present price action to predict the probability of Virax Biolabs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virax Biolabs' price. Additionally, you may evaluate how the addition of Virax Biolabs to your portfolios can decrease your overall portfolio volatility.